TMDI - Titan Medical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
56,107
32,858
12,901
22,578
38,213
Selling General and Administrative
7,618
6,803
5,966
4,925
3,525
Total Operating Expenses
63,751
39,690
18,884
27,528
41,771
Operating Income or Loss
-63,751
-39,690
-18,884
-27,528
-41,771
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
4,751
16,763
-14,720
4,197
269
Income Before Tax
-58,701
-22,639
-33,587
-23,323
-41,413
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-58,701
-22,639
-33,587
-23,323
-41,413
Net Income
-58,701
-22,639
-33,587
-23,323
-41,413
Net Income available to common shareholders
-58,701
-22,639
-33,587
-23,323
-41,413
Reported EPS
Basic
-
-1.36
-4.20
-4.80
-12.00
Diluted
-
-1.36
-4.20
-4.80
-12.00
Weighted average shares outstanding
Basic
-
16,635
7,899
4,885
3,476
Diluted
-
16,635
7,899
4,885
3,476
EBITDA
-
-39,661
-18,867
-27,503
-41,739